Figure 2.
IgM responses in mild vs. severe COVID-19 patients. (A) The positive rates of the SARS-CoV-2 IgM antibodies in mild and severe COVID-19 patients over time. P < 0.01.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.